Works matching IS 20734468 AND DT 2023 AND VI 12 AND IP 3
Results: 19
Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 60, doi. 10.3390/antib12030060
- By:
- Publication type:
- Article
Characterization of N-Terminal Asparagine Deamidation and Clipping of a Monoclonal Antibody.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 59, doi. 10.3390/antib12030059
- By:
- Publication type:
- Article
Evaluation of Molecular Simulations and Deep Learning Prediction of Antibodies' Recognition of TRBC1 and TRBC2.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 58, doi. 10.3390/antib12030058
- By:
- Publication type:
- Article
Generation of Antibodies Selectively Recognizing Epitopes in a Formaldehyde-Fixed Cell-Surface Antigen Using Virus-like Particle Display and Hybridoma Technology.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 57, doi. 10.3390/antib12030057
- By:
- Publication type:
- Article
From Cereal Grains to Immunochemistry—What Role Have Antibodies Played in the History of the Home Pregnancy Test.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 56, doi. 10.3390/antib12030056
- By:
- Publication type:
- Article
Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 55, doi. 10.3390/antib12030055
- By:
- Publication type:
- Article
Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 54, doi. 10.3390/antib12030054
- By:
- Publication type:
- Article
Exploring Parametric and Mechanistic Differences between Expi293F TM and ExpiCHO-S TM Cells for Transient Antibody Production Optimization.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 53, doi. 10.3390/antib12030053
- By:
- Publication type:
- Article
Recent Progress in Antibody Epitope Prediction.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 52, doi. 10.3390/antib12030052
- By:
- Publication type:
- Article
Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 51, doi. 10.3390/antib12030051
- By:
- Publication type:
- Article
Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 50, doi. 10.3390/antib12030050
- By:
- Publication type:
- Article
Psychiatric Symptoms in Acute and Persisting Forms of COVID-19 Associated with Neural Autoantibodies.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 49, doi. 10.3390/antib12030049
- By:
- Publication type:
- Article
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 48, doi. 10.3390/antib12030048
- By:
- Publication type:
- Article
Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 47, doi. 10.3390/antib12030047
- By:
- Publication type:
- Article
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 46, doi. 10.3390/antib12030046
- By:
- Publication type:
- Article
Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C 44 Mab-94 against Gastric Carcinomas.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 45, doi. 10.3390/antib12030045
- By:
- Publication type:
- Article
Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 44, doi. 10.3390/antib12030044
- By:
- Publication type:
- Article
Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 43, doi. 10.3390/antib12030043
- By:
- Publication type:
- Article
EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 3, p. 42, doi. 10.3390/antib12030042
- By:
- Publication type:
- Article